Introduction
Glucocorticoids (GCs) are widely used as treatments
for various diseases (1),
including systemic lupus erythematosus, idiopathic thrombocytopenic
purpura and nephrotic syndrome; however, GC use can lead to
numerous complications, the most serious of which are osteoporosis
and osteonecrosis of the femoral head (ONFH) (2). Osteoblast apoptosis is regarded as an
important pathogenic mechanism underlying these two complications
(3–6). Consistent with these findings,
previous studies have detected a large number of TUNEL-positive
osteoblasts (apoptotic cells) in the femoral head of GC-treated
rats (7,8). Therefore, the development of novel
treatments that inhibit osteoblast apoptosis is required.
The role of reactive oxygen species (ROS) in
osteoblast apoptosis has received considerable attention from
researchers. Dai et al (9)
revealed that H2O2 induces apoptosis in the
Saos-2 osteoblastic cell line, which is attenuated by curcumin via
increased protein kinase B-glycogen synthase kinase 3β signaling
and preservation of mitochondrial function. Additionally, Linares
et al (10) confirmed that
apoptosis is induced in MC3T3-E1 cells by
H2O2 and revealed that the effect is
regulated by glutaredoxin 5. Li et al (11) reported that aluminum induces
osteoblast apoptosis via the oxidative stress-mediated c-Jun
N-terminal kinase (JNK) pathway. ROS serve roles in promoting
apoptosis by inducing cytochrome c (Cyt C) release from the
mitochondria to the cytosol (12).
Furthermore, ROS have been reported to induce apoptosis of
osteoblasts via activation of a protein kinase
Cβ/p66shc/JNK signaling cascade (13). Intracellular Ca2+ is
also involved in inducing apoptosis of various cell types (14,15);
however, the role of Ca2+ in osteoblasts remains
unclear. At present, only Nam et al (16) has reported that
H2O2 increases intracellular Ca2+
levels in osteoblasts, subsequently inducing cell death.
Crocin (Fig. 1A) is
a major bioactive component extracted from saffron, which has been
reported to possess anticancer, anti-inflammatory, antioxidant and
antiapoptotic properties (17–20).
As revealed by Santhosh et al (21), crocin provides notable protection
against Vipera russelli venom-induced oxidative stress and
neutrophil apoptosis. Additionally, Oruc et al (22) reported that crocin exhibits
antiapoptotic and antioxidant effects on ischemia-reperfusion
injury induced by four-vessel occlusion. The effects of crocin on
intracellular Ca2+ signaling have received limited
attention, with the exception of a study by Liu et al
(23), which revealed that crocin
decreases the L-type Ca2+ current and inhibits
Ca2+ entry into cardiomyocytes, thereby exerting
cardioprotective effects. Notably, crocin has been demonstrated to
protect against ovariectomy-induced osteoporosis by inhibiting
oxidative stress in a rat model (24). Therefore, it has been suggested
that crocin may serve a protective role in osteoblasts. This study
hypothesized that crocin may suppress dexamethasone (Dex)-induced
osteoblast apoptosis by inhibiting the ROS/Ca2+-mediated
mitochondrial pathway.
 | Figure 1.Effects of Cro on the viability and
apoptosis of Dex-treated MC3T3-E1 osteoblasts. (A) Molecular
structure of Cro. (B) Cell viability was examined to detect the
nontoxic concentrations of Cro using an MTT assay. MC3T3-E1
osteoblasts were incubated with Cro (5, 25, 100, 400, 1,000, and
4,000 µM) for 24 and 48 h, as determined by an MTT assay. (C)
Viability of osteoblasts pretreated with Cro (5, 25 and 100 µM) for
1 h and then treated with 1 µM Dex for 24 and 48 h, as determined
by an MTT assay. (D) Apoptosis of osteoblasts pretreated with Cro
(5, 25 and 100 µM) for 1 h and then treated with 1 µM Dex for 24 h,
as determined by flow cytometry using an Annexin V-FITC/PI kit. (E)
Quantitative analysis of apoptotic cells. Data are presented as the
means ± standard deviation of three independent experiments.
**P<0.01 and ***P<0.001 vs. Ctrl; #P<0.05,
###P<0.001 vs. Dex. Cro, crocin; Ctrl, control; Dex,
dexamethasone; FITC, fluorescein isothiocyanate; PI, propidium
iodide. |
In the present study, the effects of crocin on
Dex-induced osteoblast apoptosis and its underlying mechanisms were
investigated. ROS and intracellular Ca2+ levels, and the
activity of the mitochondrial apoptotic pathway, were determined
following crocin administration in Dex-treated MC3T3-E1
osteoblasts.
Materials and methods
Materials
Crocin (cat. no. 17304), MTT (cat. no. M2128),
N-acetyl-L-cysteine (NAC, cat. no. A7250),
1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA-AM;
cat. no. 14510), H2O2 (cat. no. 88597),
ionomycin (Ion; cat. no. 407952), and dimethyl sulfoxide (cat. no.
156914) were purchased from Sigma-Aldrich (Merck KGaA, Darmstadt,
Germany). The purity of crocin was determined to be 98.06% via
high-performance liquid chromatography conducted by the Department
of Pharmacology of Wuhan University (Wuhan, China). Dex was
acquired from Shanghai Aladdin Bio-Chem Technology Co., Ltd.
(Shanghai, China, cat. no. D137736). An Annexin V-fluorescein
isothiocyanate (FITC)/propidium iodide (PI) kit was purchased from
Nanjing KeyGen Biotech Co., Ltd. (Nanjing, China; cat. no. KGA108).
JC-1 Assay (cat. no. C2006), ROS Assay (cat. no. S0033),
Mitochondria Isolation (cat. no. C3601), Bicinchoninic Acid (BCA;
cat. no. P0010) Assay and Caspase-3 Activity Assay kits (cat. no.
C1116), and phenylmethylsulfonyl fluoride (PMSF; cat. no. ST506)
were acquired from Beyotime Institute of Biotechnology (Shanghai,
China). A Fluo-3 AM kit was purchased from Dojindo Molecular
Technologies, Inc. (Kumamoto, Japan; cat. no. F026). B-cell
lymphoma-2 (Bcl-2; cat. no. 4223S), Bcl-2-associated X protein
(Bax; cat. no. 2772T), cleaved caspase-3 (cat. no. 9664T), −8 (cat.
no. 8592) and −9 (cat. no. 9509) antibodies were purchased from
Cell Signaling Technology, Inc. (Danvers, MA, USA). Cyt C antibody
was obtained from Wuhan Sanying Biotechnology (Wuhan, China; cat.
no. 10993-1-AP). GAPDH antibody was acquired from Hangzhou Goodhere
Biotechnology Co., Ltd. (Hangzhou, China; cat. no. AB-P-R 001). Cyt
C oxidase IV (COX IV; cat. no. ab16056) antibody was purchased from
Abcam (Cambridge, UK). Horseradish peroxidase-conjugated secondary
antibodies were acquired from Boster Biological Technology
(Pleasanton, CA, USA; cat. no. BA1054).
Cell culture
MC3T3-E1 osteoblasts were obtained from Wuhan
Biofavor Biotech Services Co., Ltd. (Wuhan, China). Cells were
cultured in α-minimal essential medium (Gibco; Thermo Fisher
Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal
bovine serum (Gibco; Thermo Fisher Scientific, Inc.), 100 U/ml
penicillin and 100 µg/ml streptomycin at 37°C in an atmosphere
containing 5% CO2.
Cell viability assay
Cells were cultured in 96-well plates at a density
of 5×103 cells/well. Increasing concentrations of crocin
(0, 5, 25, 100, 400, 1,000 and 4,000 µM) were added to the wells,
and cells were incubated at 37°C for 24 or 48 h. Then, nontoxic
concentrations of crocin were determined using an MTT assay and
were selected for subsequent experiments. Three concentrations (5,
25 and 100 µM) were then used to investigate the protective effects
of crocin against 1 µM Dex-induced cytotoxicity using an MTT assay.
Cells were pretreated with 5, 25 and 100 µM crocin for 1 h, and
then treated with 1 µM Dex for a further 24 or 48 h. Cells were
incubated at 37°C. The MTT assay was conducted as follows:
Following aforementioned treatment and incubation, MTT reagent (10
µl) was added to wells, and the plates were incubated at 37°C for 4
h. The medium was then discarded, and 150 µl dimethyl sulfoxide was
added to the wells to dissolve the formazan crystals. The
absorbance was detected at 568 nm using a microplate reader (Thermo
Fisher Scientific, Inc.).
Apoptosis assay
An Annexin V-FITC/PI assay was used to determine the
apoptosis of osteoblasts. Cells were pretreated with 5, 25 and 100
µM crocin for 1 h, and then treated with 1 µM Dex for a further 24
h. Cells were incubated at 37°C. Following treatment, cells were
washed twice with PBS, and were then incubated with 5 µl Annexin V
and 5 µl PI in the dark at room temperature for 15 min.
Subsequently, the cells were subjected to flow cytometry
(Beckmancoulter, Brea, CA, USA), and CytExpert 2.0 software
(Beckmancoulter) was used to determine the percentage of apoptotic
cells. Annexin V+/PI− cells were designated
as early apoptotic cells, whereas Annexin
V+/PI+ cells were identified as late
apoptotic cells. The total percentage of apoptotic cells was
calculated by adding the percentage of early apoptotic cells to the
percentage of late apoptotic cells.
Effects of increase and decrease of
ROS and Ca2+
NAC, H2O2, BAPTA-AM, and Ion
were added to cells to observe the effects of increases and
decreases in ROS and Ca2+ on the mitochondrial
transmembrane potential (Δψm), caspase-3 activity, ROS levels,
Ca2+ levels and apoptotic rate of osteoblasts. Cells
were pretreated with 100 µM Cro, 2 mM NAC, 20 µM BAP, 100 µM
H2O2 or 0.5 µM Ion for 1 h at 37°C prior to
treatment with 1 µM Dex for 24 h at 37°C. The effects of NAC and
BAP on Dex-induced mitochondrial membrane potential (Δψm) changes,
caspase-3 activation, osteoblast apoptosis, and ROS and
Ca2+ levels were evaluated. The effects of
H2O2 and Ion on the protective effects of Cro
against Dex-induced Δψm changes, caspase-3 activation, osteoblast
apoptosis, and ROS and Ca2+ levels were also
evaluated.
Measurement of the Δψm
The Δψm was measured using the JC-1 Assay kit,
according to the manufacturer's protocol. Briefly, following
treatment, cells were incubated with JC-1 solution (500 µl) at 37°C
for 20 min and were then centrifuged at 13,500 × g for 3 min at
4°C. Subsequently, the cells were washed and resuspended in 1X
incubation buffer (provided in the assay kit) three times. Finally,
the Δψm was determined by flow cytometry. The JC-1 polymer/monomer
fluorescence ratio was used to quantify the Δψm.
ROS detection
ROS levels were determined via two methods using the
ROS Assay kit: Flow cytometry and fluorescence microscopy. Briefly,
following treatment, cells were incubated with
dichlorodihydrofluorescein diacetate solution (10 µM) at 37°C for
20 min. Cells were then washed three times with serum-free medium
and washed twice with PBS. Finally, a flow cytometer was used to
quantify the fluorescence intensity as a measure of ROS production,
and data were analyzed using CytExpert 2.0 software. A fluorescence
microscope (Olympus Corporation, Tokyo, Japan) and cellSens Entry
1.17 software (Olympus Corporation) was used to observe
intracellular ROS fluorescence.
Intracellular Ca2+
detection
The Ca2+ dye Fluo-3 AM was used to
determine intracellular Ca2+ levels. Two methods, flow
cytometry and fluorescence microscopy, were employed. Following
treatment, cells were incubated with Fluo-3 AM solution (final
concentration, 5 µM) at 37°C for 30 min. The cells were then washed
twice with PBS, and the Ca2+-dependent fluorescence
intensity was determined using a flow cytometer and CytExpert 2.0
software. Fluorescence images were visualized under a fluorescence
microscope (Olympus Corporation, Tokyo, Japan) using cellSens Entry
1.17 software.
Caspase-3 activity assay
Caspase-3 activity in cells was determined using a
Caspase-3 Activity Assay kit, according to the manufacturer's
protocols. Luminescence was measured at 405 nm using a microplate
reader (Thermo Fisher Scientific, Inc.).
Western blotting
A Mitochondria Isolation kit was used to isolate
mitochondria for analysis of mitochondrial Cyt C expression,
according to the manufacturer's protocol. Following treatment,
cells were homogenized on ice in cell lysis buffer (RIPA buffer;
Beyotime Institute of Biotechnology) containing PMSF and
centrifuged at 13,500 × g for 15 min at 4°C. Subsequently, protein
concentrations were determined using a BCA kit. Equal quantities of
total protein (50 µg/lane) were separated by SDS-PAGE (separation
gel, 15%; stacking gel, 5%) and transferred to polyvinylidene
fluoride membranes. Membranes were blocked with 5% non-fat dried
milk in TBS-0.1% Tween-20 at room temperature for 2 h. incubated
with primary antibodies against Bax (1:1,000), Bcl-2 (1:1,000),
cleaved caspase-3 (1:1,000), cleaved caspase-8 (1:1,000), cleaved
caspase-9 (1:1,000), Cyt C (1:1,000), COX IV (1:2,000) and GAPDH
(1:1,000) overnight at 4°C. Subsequently, membranes were incubated
with horseradish peroxidas-conjugated secondary antibodies
(1:50,000) at 37°C for 2 h. Protein bands were visualized using
enhanced chemiluminescence (Thermo Fisher Scientific, Inc.) and the
optical density of protein bands was detected using BandScan 5.0
software (Glyko, Inc.; BioMarin Pharmaceutical, Inc., Novato, CA,
USA).
Statistical analysis
Data are presented as the means ± standard deviation
of three independent experiments. Data were analyzed using GraphPad
Prism 5.0 software (GraphPad Software, Inc., La Jolla, CA, USA).
Statistical significance was evaluated by one-way analysis of
variance followed by a Tukey-Kramer test for post hoc comparisons.
P<0.05 was considered to indicate a statistically significant
difference.
Results
Crocin protects osteoblasts against
Dex-induced cytotoxicity and apoptosis
The viability of MC3T3-E1 osteoblasts following
treatment with various concentrations of crocin was investigated to
determine a nontoxic concentration range. As presented in Fig. 1B, crocin did not exhibit cytotoxic
effects on osteoblasts at concentrations ≤400 µM. Subsequently, the
protective effects of crocin against Dex-treated MC3T3-E1
osteoblasts were determined. As presented in Fig. 1C, the viability of osteoblasts at
24 h was increased from 59.9±1.6% following treatment with 1 µM Dex
alone, to 65.1±6.7, 76.2±5.0 and 85.8±4.9% following treatment with
Dex + 5, 25 and 100 µM crocin, respectively (P<0.05). There was
no notable difference in cell viability following incubation for 24
or 48 h. Similarly, it was revealed that the percentage of
apoptotic cells at 24 h was significantly decreased from 27.0±2.9%
following incubation with 1 µM Dex alone, to 17.6±1.6, 11.6±1.4 and
8.97±0.9% following treatment with Dex + 5, 25 and 100 µM crocin,
respectively (Fig. 1D;
P<0.05).
Crocin protects osteoblasts against
Dex-induced apoptosis by inhibiting the mitochondrial apoptotic
pathway
The Δψm and expression of mitochondrial apoptotic
pathway-associated proteins were investigated. As presented in
Fig. 2A and B, Dex significantly
reduced the Δψm (JC-1 polymer/monomer fluorescence ratio) compared
with in the control group; however, crocin pretreatment reversed
the effects of Dex in a dose-dependent manner. Additionally, Dex
significantly increased the expression levels of cleaved caspase-9
and cleaved caspase-3 compared with in the control groups; these
effects were significantly attenuated by crocin pretreatment.
Conversely, Dex and crocin did not induce a significant effect on
cleaved caspase-8 expression (Fig. 2C
and D). Mitochondrial Cyt C levels were significantly decreased
and Cyt C levels were significantly increased following Dex
treatment compared with in the control group (Fig. 2E and F); crocin significantly
reversed these effects. The relative expression levels of Bax and
Bcl-2 exhibited similar alterations; Bax expression was increased
and Bcl-2 expression was decreased by Dex, whereas these effects
were reversed by crocin.
 | Figure 2.Effects of Cro on the mitochondrial
apoptotic pathway in Dex-treated MC3T3-E1 osteoblasts. Cells were
pretreated with Cro (5, 25 and 100 µM) for 1 h and were then
treated with 1 µM Dex for 24 h. (A) Δψm of osteoblasts, as
determined using a JC-1 Assay kit. (B) Quantitative analysis of the
Δψm, as determined by calculating the JC-1 polymer/monomer
fluorescence ratio. (C) Western blot analysis of cleaved caspase-9,
cleaved caspase-8 and cleaved caspase-3 protein expression. (D)
Semi-quantitative analysis of the protein expression levels of
cleaved caspase-9, cleaved caspase-8 and cleaved caspase-3. (E)
Western blot analysis and semi-quantitative analysis of Bcl-2 and
Bax protein expression. (F) Western blot analysis and
semi-quantitative analysis of Mito Cyt C protein expression. (G)
Western blot analysis and semi-quantitative analysis of Cyto Cyt C
protein expression. Data are presented as the means ± standard
deviation of three independent experiments. ***P<0.001 vs. Ctrl;
#P<0.05, ##P<0.01 and
###P<0.001 vs. Dex. Δψm, mitochondrial transmembrane
potential; Bcl-2, B-cell lymphoma-2; Bax, Bcl-2-associated X
protein; Cro, crocin; Ctrl, control; Cyt C, cytochrome c;
COX IV, Cyt C oxidase IV; Cyto, cytosolic; Dex, dexamethasone;
Mito, mitochondrial. |
ROS and intracellular Ca2+
are involved in the protective effects of crocin on Dex-treated
osteoblasts
The roles of ROS and intracellular Ca2+
in the protective effects of crocin on Dex-treated osteoblasts were
investigated. It was demonstrated that Dex significantly increased
ROS and intracellular Ca2+ levels compared with in the
control group, whereas crocin pretreatment significantly inhibited
these effects in a dose-dependent manner (Fig. 3).
Crocin induces antiapoptotic effects
on Dex-treated osteoblasts via ROS/Ca2+ signaling
As presented in Fig.
4A-C, treatment with NAC or BAPTA-AM attenuated Dex-induced
apoptosis, loss of the Δψm and activation of caspase-3 in
osteoblasts. Furthermore, it was demonstrated that
H2O2 and Ion attenuated the protective
effects of crocin on Dex-induced apoptosis, alterations in the Δψm
and caspase-3 activation (Fig.
4D-F). The results indicated that the protective effects of
crocin were mediated via alterations in intracellular
Ca2+ and ROS levels.
 | Figure 4.Effects of ROS and Ca2+
signaling on Dex- and Cro-treated MC3T3-E1 osteoblasts. Cells were
pretreated with 100 µM Cro, 2 mM NAC, 20 µM BAP, 100 µM
H2O2 or 0.5 µM Ion for 1 h prior to treatment
with 1 µM Dex for 24 h. Effects of NAC and BAP on Dex-induced (A)
Δψm loss, (B) caspase-3 activation and (C) apoptosis of
osteoblasts. Effects of H2O2 and Ion on the
protective effects of Cro against Dex-induced (D) loss of the Δψm,
(E) caspase-3 activation and (F) apoptosis. Data are presented as
the means ± standard deviation of three independent experiments.
***P<0.001 vs. control; #P<0.05,
##P<0.01 and ###P<0.001 vs. Dex;
&P<0.05, &&P<0.01 and
&&&P<0.001 vs. Dex + Cro. Δψm,
mitochondrial transmembrane potential; BAP,
1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid; Cro,
crocin; Dex, dexamethasone; Ion, ionomycin; NAC,
N-acetyl-L-cysteine. |
Association between ROS and
intracellular Ca2+ in Dex- and crocin-treated
osteoblasts
The association between ROS and intracellular
Ca2+ in Dex- and crocin-treated osteoblasts was further
investigated. As presented in Fig.
5A-C, NAC and BAPTA-AM significantly decreased Dex-induced ROS
generation and intracellular Ca2+ accumulation compared
with Dex treatment alone. Additionally, as presented in Fig. 5D-F, H2O2 and
Ion treatment significantly attenuated the protective effects of
crocin on Dex-induced ROS generation and intracellular
Ca2+ accumulation. The results suggested that ROS and
intracellular Ca2+ levels may be associated and
collectively contribute to apoptosis.
 | Figure 5.Association between ROS and
intracellular Ca2+ in Dex- and Cro-treated MC3T3-E1
osteoblasts. Cells were pretreated with 100 µM Cro, 2 mM NAC, 20 µM
BAP, 100 µM H2O2 or 0.5 µM Ion for 1 h prior
to treatment with 1 µM Dex for 24 h. (A) Visualization of ROS
generation and intracellular Ca2+ by fluorescence
microscopy (magnification, ×100). Quantitative analysis of (B) ROS
production and (C) intracellular Ca2+ levels following
pretreatment with NAC or BAP, and treatment with Dex, as determined
via flow cytometry. (D) Visualization of ROS generation and
intracellular Ca2+ by fluorescence microscopy
(magnification, ×100). Quantitative analysis of (E) ROS production
and (F) intracellular Ca2+ levels following pretreatment
with Cro with or without H2O2 and Ion, and
treatment with Dex, as determined via flow cytometry. Data are
presented as the means ± standard deviation of three independent
experiments. ***P<0.001 vs. Ctrl; ###P<0.001 vs.
Dex; &&&P<0.001 vs. Dex + Cro. BAP,
1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid; Cro,
crocin; Dex, dexamethasone; Ion, ionomycin; NAC,
N-acetyl-L-cysteine; ROS, reactive oxygen species. |
Discussion
Osteoblast apoptosis remains a significant cause of
GC-induced osteoporosis and ONFH (25,26).
Crocin has been reported to exert antioxidative and antiapoptotic
effects (27,28). Cao et al (24) revealed that crocin ameliorates
ovariectomy-induced osteoporosis in rats by inhibiting oxidative
stress; however, it is yet to be determined whether crocin exerts
protective effects against Dex-induced osteoblast apoptosis. In the
present study, it was observed that crocin significantly inhibited
Dex-induced osteoblast apoptosis in a dose-dependent manner, thus
suggesting that crocin may be considered a potential natural
treatment for GC-induced bone diseases.
Numerous studies have reported that the
antiapoptotic effects of crocin protect various tissues and organs
(19,29–31),
whereas others have observed that its proapoptotic effects promote
apoptosis in tumor cells (32–34).
Therefore, crocin appears to exhibit antiapoptotic and proapoptotic
properties; however, the dose ranges of crocin used in these
studies may be responsible for these varied effects, as doses
<500 µM tend to induce antiapoptotic effects, whereas those
>500 µM induce proapoptotic effects. The present findings were
similar; concentrations ≤400 µM did not exhibit toxicity, whereas
those >1,000 µM significantly reduced osteoblast viability.
To identify the mechanisms underlying the
antiapoptotic effects of crocin on Dex-induced apoptosis of
osteoblasts, the mitochondrial apoptotic pathway was investigated.
The results revealed that Dex exposure decreased the Δψm, whereas
crocin treatment reversed this effect in a dose-dependent manner.
In addition, Dex activated caspase-9, but did not alter caspase-8
activity, suggesting that the mitochondrial pathway, but not the
death receptor-mediated pathway, contributed to Dex-induced
osteoblast apoptosis. These results were consistent with the
findings of Li et al (35).
Furthermore, it was demonstrated that crocin treatment attenuated
Dex-induced caspase-9 activation, suggesting that crocin inhibited
the mitochondrial apoptotic pathway. Loss of the Δψm is associated
with release of Cyt C from the mitochondria to the cytosol,
subsequently leading to the activation of caspase-3 and apoptosis
(36). A decrease in the Bcl-2/Bax
ratio can induce loss of the Δψm (37,38).
Consistent with these findings, the results of the present study
indicated that Cyt C translocated from the mitochondria to the
cytosol following Dex treatment, and that crocin attenuated this
effect. The expression levels of Bcl-2, Bax and cleaved caspase-3
in the present study also supported the hypothesis that crocin may
suppress the mitochondrial apoptosis pathway in Dex-treated
osteoblasts.
ROS, which are primarily generated in the
mitochondria, induce loss of the Δψm and serve an important role in
osteoblast apoptosis (11,39). Almeida et al (13) observed elevated ROS levels and
increased apoptosis in Dex-treated UAMS-32 osteoblasts; however,
these effects are inhibited by the antioxidant NAC. The present
study also revealed that ROS was involved in Dex-induced osteoblast
apoptosis, and that crocin attenuated ROS generation. Inhibition of
ROS with NAC suppressed Dex-induced apoptosis. Furthermore,
H2O2 suppressed the antiapoptotic effects of
crocin on Dex-treated osteoblasts. Intracellular Ca2+
overload has also been reported to lead to loss of the Δψm and the
induction of apoptosis (40,41).
Pretreatment with the calcium chelator BAPTA-AM partially
suppresses apoptosis (42).
Similarly, it was observed in the present study that Dex increased
intracellular Ca2+ concentrations, and that crocin
reversed the effect. Notably, BAPTA-AM also suppressed Dex-induced
apoptosis, whereas the calcium ionophore Ion reversed the
antiapoptotic effects of crocin on Dex-treated osteoblasts. Zhang
et al (43) reported that
NAC and BAPTA-AM suppress the eicosapentaenoic acid-induced
apoptosis of HepG2 cells, and suggested the involvement of the
ROS-Ca2+-JNK mitochondrial pathways. Based on the
present findings, it was hypothesized that crocin may induce
antiapoptotic effects on Dex-induced osteoblasts by inhibiting the
ROS/Ca2+-mediated mitochondrial pathway.
The results of the present study suggested that ROS
and intracellular Ca2+ levels are associated in
Dex-treated cells or Dex- and crocin-treated cells. Notably,
treatment with H2O2 or NAC also affected
intracellular Ca2+ levels, whereas treatment with Ion or
BAPTA-AM also affected ROS levels. Furthermore, a number of studies
have reported that ROS contributes to intracellular Ca2+
overload (16,44), and other studies have demonstrated
that intracellular Ca2+ overload leads to increased ROS
production (45,46). Wang et al (44) suggested that oxidative stress
decreases the efficiency of ATPase, thus contributing to
voltage-gated calcium ion influx and subsequently apoptosis. Lipton
and Nicotera (45) suggested that
cytosolic Ca2+ overload leads to depolarization of the
mitochondria, subsequently contributing to the accumulation of ROS;
however, the potential mechanisms are complex and requires further
investigation.
In conclusion, crocin exerted protective effects
against apoptosis in Dex-induced MC3T3-E1 osteoblasts. Inactivation
of the ROS/Ca2+-mediated mitochondrial pathway may be
involved in the inhibitory effects of crocin on osteoblast
apoptosis. The present study may promote further investigation into
the application of crocin as a treatment for GC-induced
osteoporosis and ONFH.
Acknowledgements
Not applicable.
Funding
The present study was supported by a grant from the
National Natural Science Foundation of China (grant no.
81672154).
Availability of data and materials
All data generated and/or analyzed during this study
are included in this published article.
Author's contributions
ZN, SD and HP designed the study. ZN, SD, LZ, QL and
SC performed the experiments. ZN, SD and LZ performed data
analysis. ZN drafted the manuscript. ZN, SD, LZ and HP revised the
manuscript. All authors reviewed the manuscript.
Ethics approval and consent to
participate
Not applicable.
Patient consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing
interests.
References
|
1
|
Deng S, Dai G, Chen S, Nie Z, Zhou J, Fang
H and Peng H: Dexamethasone induces osteoblast apoptosis through
ROS-PI3K/AKT/GSK3β signaling pathway. Bio Pharmacother.
110:602–608. 2019. View Article : Google Scholar
|
|
2
|
Feng Z, Zheng W, Tang Q, Cheng L, Li H, Ni
W and Pan X: Fludarabine inhibits STAT1-mediated up-regulation of
caspase-3 expression in dexamethasone-induced osteoblasts apoptosis
and slows the progression of steroid-induced avascular necrosis of
the femoral head in rats. Apoptosis. 22:1001–1012. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weinstein RS, Jilka RL, Parfitt AM and
Manolagas SC: Inhibition of osteoblastogenesis and promotion of
apoptosis of osteoblasts and osteocytes by glucocorticoids.
Potential mechanisms of their deleterious effects on bone. J Clin
Invest. 102:274–282. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zalavras C, Shah S, Birnbaum MJ and
Frenkel B: Role of apoptosis in glucocorticoid-induced osteoporosis
and osteonecrosis. Crit Rev Eukaryot Gene Expr. 13:221–235. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kerachian MA, Séguin C and Harvey EJ:
Glucocorticoids in osteonecrosis of the femoral head: A new
understanding of the mechanisms of action. J Steroid Biochem Mol
Biol. 114:121–128. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen F, Zhang L, OuYang Y, Guan H, Liu Q
and Ni B: Glucocorticoid induced osteoblast apoptosis by increasing
E4BP4 expression via up-regulation of Bim. Calcif Tissue Int.
94:640–647. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen S, Li J, Peng H, Zhou J and Fang H:
Administration of erythropoietin exerts protective effects against
glucocorticoid-induced osteonecrosis of the femoral head in rats.
Int J Mol Med. 33:840–848. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng H, Yang E, Peng H, Li J, Chen S,
Zhou J, Fang H, Qiu B and Wang Z: Gastrodin prevents
steroid-induced osteonecrosis of the femoral head in rats by
anti-apoptosis. Chin Med J (Engl). 127:3926–3931. 2014.PubMed/NCBI
|
|
9
|
Dai P, Mao Y, Sun X, Li X, Muhammad I, Gu
W, Zhang D, Zhou Y, Ni Z, Ma J and Huang S: Attenuation of
oxidative stress-induced osteoblast apoptosis by curcumin is
associated with preservation of mitochondrial functions and
increased Akt-GSK3β signaling. Cell Physiol Biochem. 41:661–677.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Linares GR, Xing W, Govoni KE, Chen ST and
Mohan S: Glutaredoxin 5 regulates osteoblast apoptosis by
protecting against oxidative stress. Bone. 44:795–804. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li X, Han Y, Guan Y, Zhang L, Bai C and Li
Y: Aluminum induces osteoblast apoptosis through the oxidative
stress-mediated JNK signaling pathway. Biol Trace Elem Res.
150:502–508. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ding G, Zhao J and Jiang D: Allicin
inhibits oxidative stress-induced mitochondrial dysfunction and
apoptosis by promoting PI3K/AKT and CREB/ERK signaling in
osteoblast cells. Exp Ther Med. 11:2553–2560. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Almeida M, Han L, Ambrogini E, Weinstein
RS and Manolagas SC: Glucocorticoids and tumor necrosis factor
alpha increase oxidative stress and suppress Wnt protein signaling
in osteoblasts. J Biol Chem. 286:44326–44335. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li L, Tan H, Gu Z, Liu Z, Geng Y, Liu Y,
Tong H, Tang Y, Qiu J and Su L: Heat stress induces apoptosis
through a Ca2+-mediated mitochondrial apoptotic pathway
in human umbilical vein endothelial cells. PLoS One. 9:e1110832014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang CL, Xia Y, Nie JZ, Zhou M, Zhang RP,
Niu LL, Hou LH and Cao XH: Musca domestica larva lectin induces
apoptosis in BEL-7402 cells through a Ca(2+)/JNK-mediated
mitochondrial pathway. Cell Biochem Biophys. 66:319–329. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nam SH, Jung SY, Yoo CM, Ahn EH and Suh
CK: H2O2 enhances Ca2+ release
from osteoblast internal stores. Yonsei Med J. 43:229–235. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hoshyar R and Mollaei H: A comprehensive
review on anticancer mechanisms of the main carotenoid of saffron,
crocin. J Pharm Pharmacol. 69:1419–1427. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yarijani ZM, Pourmotabbed A, Pourmotabbed
T and Najafi H: Crocin has anti-inflammatory and protective effects
in ischemia-reperfusion induced renal injuries. Iran J Basic Med
Sci. 20:753–759. 2017.PubMed/NCBI
|
|
19
|
Ben Salem I, Boussabbeh M, Kantaoui H,
Bacha H and Abid-Essefi S: Crocin, the main active saffron
constituent, mitigates dichlorvos-induced oxidative stress and
apoptosis in HCT-116 cells. Biomed Pharmacother. 82:65–71. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang X, Huo F, Liu B, Liu J, Chen T, Li J,
Zhu Z and Lv B: Crocin inhibits oxidative stress and
pro-inflammatory response of microglial cells associated with
diabetic retinopathy through the activation of PI3K/Akt signaling
pathway. J Mol Neurosci. 61:581–589. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Santhosh MS, Sundaram MS, Sunitha K,
Jnaneshwari S, Devaraja S, Kemparaju K and Girish KS: Propensity of
crocin to offset Vipera russelli venom induced oxidative
stress mediated neutrophil apoptosis: A biochemical insight.
Cytotechnology. 68:73–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oruc S, Gönül Y, Tunay K, Oruc OA, Bozkurt
MF, Karavelioğlu E, Bağcıoğlu E, Coşkun KS and Celik S: The
antioxidant and antiapoptotic effects of crocin pretreatment on
global cerebral ischemia reperfusion injury induced by four vessels
occlusion in rats. Life Sci. 154:79–86. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu T, Chu X, Wang H, Zhang X, Zhang Y,
Guo H, Liu Z, Dong Y, Liu H, Liu Y, et al: Crocin, a carotenoid
component of Crocus cativus, exerts inhibitory effects on L-type
Ca(2+) current, Ca(2+) transient, and contractility in rat
ventricular myocytes. Can J Physiol Pharmacol. 94:302–308. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cao PC, Xiao WX, Yan YB, Zhao X, Liu S,
Feng J, Zhang W, Wang J, Feng YF and Lei W: Preventive effect of
crocin on osteoporosis in an ovariectomized rat model. Evid Based
Complement Alternat Med. 2014:8251812014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Z, Jin A and Yan D: MicroRNA206
contributes to the progression of steroidinduced avascular necrosis
of the femoral head by inducing osteoblast apoptosis by suppressing
programmed cell death 4. Mol Med Rep. 17:801–808. 2018.PubMed/NCBI
|
|
26
|
Yun SI, Yoon HY, Jeong SY and Chung YS:
Glucocorticoid induces apoptosis of osteoblast cells through the
activation of glycogen synthase kinase 3beta. J Bone Miner Metab.
27:140–148. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dianat M, Radan M, Badavi M, Mard SA,
Bayati V and Ahmadizadeh M: Crocin attenuates cigarette
smoke-induced lung injury and cardiac dysfunction by anti-oxidative
effects: The role of Nrf2 antioxidant system in preventing
oxidative stress. Respir Res. 19:582018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Razavi BM, Hosseinzadeh H, Abnous K, Khoei
A and Imenshahidi M: Protective effect of crocin against apoptosis
induced by subchronic exposure of the rat vascular system to
diazinon. Toxicol Ind Health. 32:1237–1245. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yousefsani BS, Mehri S, Pourahmad J and
Hosseinzadeh H; Crocin prevents sub-cellular organelle damage,
proteolysis apoptosis in rat hepatocytes, : A justification for its
hepatoprotection. Iran J Pharm Res. 17:553–562. 2018.PubMed/NCBI
|
|
30
|
Boussabbeh M, Prola A, Ben Salem I,
Guilbert A, Bacha H, Lemaire C and Abis-Essefi S: Crocin and
quercetin prevent PAT-induced apoptosis in mammalian cells:
Involvement of ROS-mediated ER stress pathway. Environ Toxicol.
31:1851–1858. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thushara RM, Hemshekhar M, Santhosh MS,
Jnaneshwari S, Nayaka SC, Naveen S, Kemparaju K and Girish KS:
Crocin, a dietary additive protects platelets from oxidative
stress-induced apoptosis and inhibits platelet aggregation. Mol
Cell Biochem. 373:73–83. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Amin A, Bajbouj K, Koch A, Gandesiri M and
Schneider-Stock R: Defective autophagosome formation in p53-null
colorectal cancer reinforces crocin-induced apoptosis. Int J Mol
Sci. 16:1544–1561. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rezaee R, Jamialahmadi K, Riahi Zanjani B,
Mahmoudi M, Abnous K, Zamani Taghizadeh Rabe S, Tabasi N, Zali M,
Rezaee M, Amin B and Karimi G: Crocin effects on human myeloma
cells regarding intracellular redox state, DNA fragmentation, and
apoptosis or necrosis profile. Jundishapur J Nat Pharm Prod.
9:e201312014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hoshyar R, Bathaie SZ and Sadeghizadeh M:
Crocin triggers the apoptosis through increasing the Bax/Bcl-2
ratio and caspase activation in human gastric adenocarcinoma, AGS,
cells. DNA Cell Biol. 32:50–57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li J, He C, Tong W, Zou Y, Li D, Zhang C
and Xu W: Tanshinone IIA blocks dexamethasone-induced apoptosis in
osteoblasts through inhibiting Nox4-derived ROS production. Int J
Clin Exp Pathol. 8:13695–13706. 2015.PubMed/NCBI
|
|
36
|
Bak DH, Kim HD, Kim YO, Park CG, Han SY
and Kim JJ: Neuroprotective effects of 20(S)-protopanaxadiol
against glutamate-induced mitochondrial dysfunction in PC12 cells.
Int J Mol Med. 37:378–386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lv R, Du L, Lu C, Wu J, Ding M, Wang C,
Mao N and Shi Z: Allicin protects against
H2O2-induced apoptosis of PC12 cells via the
mitochondrial pathway. Exp Ther Med. 14:2053–2059. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Giménez-Cassina A and Danial NN:
Regulation of mitochondrial nutrient and energy metabolism by BCL-2
family proteins. Trends Endocrinol Metab. 26:165–175. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gan X, Huang S, Yu Q, Yu H and Yan SS:
Blockade of Drp1 rescues oxidative stress-induced osteoblast
dysfunction. Biochem Biophys Res Commun. 468:719–725. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Assaf H, Azouri H and Pallardy M:
Ochratoxin A induces apoptosis in human lymphocytes through down
regulation of Bcl-xL. Toxicol Sci. 79:335–344. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu L, Wang D, Wang J and Wang S: The
nitric oxide prodrug JS-K induces Ca(2+)-mediated apoptosis in
human hepatocellular carcinoma HepG2 cells. J Biochem Mol Toxicol.
30:192–199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang J, Zhu H, Liu X and Liu Z: Oxidative
stress and Ca(2+) signals involved on cadmium-induced apoptosis in
rat hepatocyte. Biol Trace Elem Res. 161:180–189. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang Y, Han L, Qi W, Cheng D, Ma X, Hou
L, Cao X and Wang C: Eicosapentaenoic acid (EPA) induced apoptosis
in HepG2 cells through ROS-Ca(2+)-JNK mitochondrial pathways.
Biochem Biophys Res Commun. 456:926–932. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang W, Zheng LL, Wang F, Hu ZL, Wu WN, Gu
J and Chen JG: Tanshinone IIA attenuates neuronal damage and the
impairment of long-term potentiation induced by hydrogen peroxide.
J Ethnopharmacol. 134:147–155. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lipton SA and Nicotera P: Calcium, free
radicals and excitotoxins in neuronal apoptosis. Cell Calcium.
23:165–171. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen H, Gao W, Yang Y, Guo S, Wang H, Wang
W, Zhang S, Zhou Q, Xu H, Yao J, et al: Inhibition of VDAC1
prevents Ca2+-mediated oxidative stress and apoptosis
induced by 5-aminolevulinic acid mediated sonodynamic therapy in
THP-1 macrophages. Apoptosis. 19:1712–1726. 2014. View Article : Google Scholar : PubMed/NCBI
|
